NCT06910657 2026-03-02IDOV-Immune for Advanced Solid TumorsViroMissile, Inc.Phase 1 Recruiting78 enrolled
NCT04725331 2025-11-21A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid TumorsTransgenePhase 1/2 Terminated31 enrolled